Summary of Significant Accounting Policies - Summary of Product Revenues by Product Line (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023		Dec. 31, 2022	Dec. 31, 2021
Revenue from External Customer [Line Items]
Revenue	$ 638,764		$ 801,536	$ 670,534
Filtration Products [Member]
Revenue from External Customer [Line Items]
Revenue	347,781	[1]	495,930
Chromatography Products [Member]
Revenue from External Customer [Line Items]
Revenue	126,629	[1]	131,680
Process Analytics Products [Member]
Revenue from External Customer [Line Items]
Revenue	56,820	[1]	53,512
Proteins Products [Member]
Revenue from External Customer [Line Items]
Revenue	103,463	[1]	114,320
Other products [Member]
Revenue from External Customer [Line Items]
Revenue	3,688	[1]	5,741
Products
Revenue from External Customer [Line Items]
Revenue	$ 638,381	[1]	$ 801,183	$ 670,319

[1] 2023 revenue for filtration products includes revenue related to FlexBiosys, Inc. (“FlexBiosys”) from April 17, 2023, as well as Metenova Holding AB (“Metenova”) from October 2, 2023.